Affimed

YTD

ALL

Why Robinhood?

You can watch Affimed and buy or sell other stocks, ETFs, and their options commission-free!

About AFMD

Affimed NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of cancer immunotherapies. The company’s proprietary ROCK platform enables a tumor-targeted approach to recognize and kill a range of hematologic and solid tumors, enabling a broad pipeline of wholly-owned and partnered single agent and combination therapy programs.

CEO

Shawn M. Leland, PharmD

CEOShawn M. Leland, PharmD

Employees

—

Employees—

Headquarters

Mannheim, Baden Wuerttemberg

HeadquartersMannheim, Baden Wuerttemberg

Founded

2000

Founded2000

Employees

—

Employees—

AFMD Key Statistics

Market cap

1.50K

Market cap1.50K

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

19.60K

Average volume19.60K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$0.05

52 Week high$0.05

52 Week low

—

52 Week low—

Stock Snapshot

With a market cap of 1.5K, Affimed(AFMD) trades at $5.91.

On 2026-10-27, Affimed(AFMD) stock opened at —, reached a high of —, and a low of —.

Affimed(AFMD) shares are trading with a volume of 0, against a daily average of 19.6K.

People also own

Based on the portfolios of people who own AFMD. This list is generated using Robinhood data, and it’s not a recommendation.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.